Literature DB >> 18193117

Vascular density and VEGF expression in hepatic lesions.

Sergey V Brodsky1, Natalia Mendelev, Myron Melamed, Gita Ramaswamy.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor worldwide and the third most common cause of cancer-related death. HCC is a hypervascular tumor expressing several angiogenic factors. The correlation between plasma levels of Vascular Endothelial Growth Factor (VEGF) and the survival of patients with HCC was demonstrated earlier. However, a relationship between the expression of VEGF and vascular density in the HCC and non-malignant hepatic parenchyma has not been investigated.
MATERIAL AND METHODS: We studied the expression of VEGF and vascular density in normal hepatic parenchyma, cirrhosis and HCC using a computer-based analysis of immunohistochemical stainings and confirmed it by Western Blot.
RESULTS: The vascular density in the areas of HCC and internodular fibrotic tissue in cirrhotic liver was significantly higher (185%; 146% respectively) than in non-neoplastic hepatic parenchyma. Additionally, cirrhotic nodules were characterized by significantly lower vascularization (71%) compared with normal liver. There was a strong correlation between the levels of VEGF expression in tissue and the number of vessels (r=0.98, R2=0.9696).
CONCLUSION: Cirrhosis and HCC are characterized by different degrees of vascularization, which has been quantitated by a novel computer-based analysis of immunohistochemical stainings. One of the major stimuli for angiogenesis in these liver diseases could be VEGF, as the VEGF expression was higher in HCC and diminished in cirrhotic nodules, thus strongly correlating with the degree of vascularization. Our findings demonstrate that angiogenesis may play an important role in the pathogenesis of these conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18193117

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  17 in total

Review 1.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

Review 2.  Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment.

Authors:  Davide Roccarina; Matteo Garcovich; Maria Elena Ainora; Laura Riccardi; Maurizio Pompili; Antonio Gasbarrini; Maria Assunta Zocco
Journal:  World J Hepatol       Date:  2015-07-18

3.  Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.

Authors:  Guang-Qin Xiao; Chang Liu; Da-Li Liu; Jia-Yin Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

4.  The neutrophil-to-lymphocyte ratio as a predictor for recurrence of colorectal liver metastases following radiofrequency ablation.

Authors:  Zhihui Chang; Jiahe Zheng; Yujia Ma; Jian Zhao; Chuanzhuo Wang; Zhaoyu Liu
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

5.  Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation.

Authors:  Gun Hyung Na; Dong Goo Kim; Jae Hyun Han; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

6.  A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.

Authors:  Olfat Hammam; Ola Mahmoud; Manal Zahran; Azza Sayed; Rabab Salama; Karim Hosny; Ahmed Farghly
Journal:  Gastrointest Cancer Res       Date:  2013-07

7.  Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma.

Authors:  Atsushi Nanashima; Toshiyuki Nakayama; Yorihisa Sumida; Takafumi Abo; Hiroaki Takeshita; Kenichirou Shibata; Shigekazu Hidaka; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

8.  Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study.

Authors:  Kinnosuke Matsumoto; Akihiro Tamiya; Yoshinobu Matsuda; Yoshihiko Taniguchi; Shinji Atagi; Hayato Kawachi; Motohiro Tamiya; Satoshi Tanizaki; Junji Uchida; Kiyonobu Ueno; Takafumi Yanase; Hidekazu Suzuki; Tomonori Hirashima
Journal:  Transl Lung Cancer Res       Date:  2021-04

9.  The evaluation of anti-angiogenic effects of Endostar on rabbit VX2 portal vein tumor thrombus using perfusion MSCT.

Authors:  Guoquan Feng; Zhen Lei; Dongqing Wang; Na Xu; Qiang Wei; Dinuo Li; Jingyi Liu
Journal:  Cancer Imaging       Date:  2014-04-28       Impact factor: 3.909

10.  The anti-tumor effect of a polypeptide extracted from Tegillarca granosa Linnaeus on renal metastatic tumor OS-RC-2 cells.

Authors:  Wenhua Xu; Xiaoying Kong; Changqing Jiang; Xiaoyan Liu; Luo Xu
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.